Cargando…
Examination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26
The therapeutic properties of cannabinoids have been well demonstrated but are overshadowed by such adverse effects as cognitive and motor dysfunction, as well as their potential for addiction. Recent research on the natural lipid ligands of cannabinoid receptors, also known as endocannabinoids, has...
Autores principales: | Thanos, Panayotis K., Clavin, Brendan H., Hamilton, John, O’Rourke, Joseph R., Maher, Thomas, Koumas, Christopher, Miao, Erick, Lankop, Jessenia, Elhage, Aya, Haj-Dahmane, Samir, Deutsch, Dale, Kaczocha, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820685/ https://www.ncbi.nlm.nih.gov/pubmed/27092087 http://dx.doi.org/10.3389/fpsyt.2016.00054 |
Ejemplares similares
-
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms
por: Kaczocha, Martin, et al.
Publicado: (2015) -
Pharmacological Inhibition of Brain Fatty Acid Binding Protein Reduces Ethanol Consumption in Mice
por: Figueiredo, Antonio, et al.
Publicado: (2017) -
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
por: Al-Jameel, Waseem, et al.
Publicado: (2017) -
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
por: Al-Jameel, Waseem, et al.
Publicado: (2020) -
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs
por: Berger, William T., et al.
Publicado: (2012)